Biomea Fusion, Inc. Active Patents
9 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2025-03-28: Application 19094187; Invention HETEROCYCLIC GLP-1R AGONISTS; Applicant BIOMEA FUSION, INC.; Status Patented Case.
- 2024-01-30: Application 18427226; Invention CRYSTALLINE FORMS OF N-[4-[4-(4-MORPHOLINYL)-7H-PYRROLO[2,3-d]PYRIMIDIN-6-YL]PHENYL]-4-[[3(R)-[(1-OXO-2-PROPEN-1-YL)AMINO]-1-PIPERIDINYL]METHYL]-2-PYRIDINECARBOXAMIDE; Applicant BIOMEA FUSION, INC.; Status Patented Case.
- 2023-11-06: Application 18387420; Invention INHIBITORS OF MENIN-MLL INTERACTION; Applicant BIOMEA FUSION, INC.; Status Patented Case.
- 2023-07-31: Application 18228602; Invention SUBSTITUTED PYRIDINES AS IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTION; Applicant BIOMEA FUSION, INC.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-28 | 19094187 | HETEROCYCLIC GLP-1R AGONISTS | BIOMEA FUSION, INC. | Patented Case | 2026-05-05 | 12617783 | US20250304572A1 | Xiaodong Wang Thorsten A. Kirschberg Johannes H. Voigt Thomas Butler Ravindra B. Upasani Yongli Su Thu Phan James T. Palmer Neil Howard Squires Yeyu Cao Solomon B. Ungashe Nan-Horng Lin Mini Balakrishnan Petr Jansa Satish Goud Pappali | United States United States United States United States United States United States United States Australia United States United States United States United States United States United States United States | TRAN, ERIC |
| 2024-01-30 | 18427226 | CRYSTALLINE FORMS OF N-[4-[4-(4-MORPHOLINYL)-7H-PYRROLO[2,3-d]PYRIMIDIN-6-YL]PHENYL]-4-[[3(R)-[(1-OXO-2-PROPEN-1-YL)AMINO]-1-PIPERIDINYL]METHYL]-2-PYRIDINECARBOXAMIDE | BIOMEA FUSION, INC. | Patented Case | 2025-02-04 | 12215113 | US20240300950A1 | Satish Goud Puppali James T. Palmer Thorsten A. Kirschberg Angelina Sau Man Wong Heow Meng Tan Jay Li Jing Lin Ming Gao Junlu Ding Shuang Li Yuyao GU Hongyan He Bo Zheng Yanjing Zhou Mei You | United States Australia United States United States United States United States United States China China United States China China China China China | WILLIS, DOUGLAS M |
| 2023-11-06 | 18387420 | INHIBITORS OF MENIN-MLL INTERACTION | BIOMEA FUSION, INC. | Patented Case | 2025-04-15 | 12275739 | US20240140953A1 | Thomas BUTLER Jim PALMER Ravi UPASANI Matthew WELSCH Sridhar VEMPATI Brendan KELLY Edward PAINTER | United States Australia United States United States United States Ireland United States | MOORE, SUSANNA |
| 2023-07-31 | 18228602 | SUBSTITUTED PYRIDINES AS IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTION | BIOMEA FUSION, INC. | Patented Case | 2024-10-15 | 12116371 | US20230391784A1 | Thomas BUTLER Jim PALMER Ravi UPASANI Matthew WELSCH Sridhar VEMPATI Brendan KELLY Edward PAINTER | United States Australia United States United States United States Ireland United States | WILLIS, DOUGLAS M |
| 2023-01-09 | 18094929 | IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTION | BIOMEA FUSION, INC. | Patented Case | 2024-09-03 | 12077544 | US20230227458A1 | Thomas BUTLER Jim PALMER Ravi UPASANI Matthew WELSCH Sridhar VEMPATI Brendan KELLY Edward PAINTER | United States Australia United States United States United States Ireland United States | WILLIS, DOUGLAS M |
| 2022-12-29 | 18148311 | PYRAZINE COMPOUNDS AS INHIBITORS OF FLT3 | Biomea Fusion, Inc. | Patented Case | 2024-04-02 | 11945785 | US20230339867A1 | David Sperandio Xiaodong Wang Thorsten A. Kirschberg James T. Palmer Thomas Butler Solomon B. Ungashe Neil Howard Squires Nan-Horng Lin Ravindra B. Upasani Amna Trinity-Turjuman Adam Yongli Su Thu Phan | United States United States United States Australia United States United States United States United States United States United States United States United States | MURRAY, JEFFREY H |
| 2022-08-10 | 17885493 | COVALENT INHIBITORS OF MENIN-MLL INTERACTION FOR DIABETES MELLITUS | BIOMEA FUSION, INC. | Patented Case | 2025-03-18 | 12251385 | US20230120115A1 | Thomas BUTLER James T. PALMER | United States Australia | TRAN, ERIC |
| 2022-08-10 | 17885213 | CRYSTALLINE FORMS OF N-[4-[4-(4-MORPHOLINYL)-7H-PYRROLO[2,3-d]PYRIMIDIN-6-YL]PHENYL]-4-[[3(R)-[(1-OXO-2-PROPEN-1-YL)AMINO]-1-PIPERIDINYL]METHYL]-2-PYRIDINECARBOXAMIDE AS AN IRREVERSIBLE INHIBITOR OF MENIN-MLL INTERACTION | BIOMEA FUSION, INC. | Patented Case | 2024-06-25 | 12018032 | US20230086137A1 | Priyanka SOMANATH Daniel LU Taisei KINOSHITA Brian LAW Thomas BUTLER James T. PALMER Nan-Horng LIN Heow Meng TAN Angelina Sau Man WONG Siyi JIANG Hongyan HE | United States United States United States United States United States Australia United States United States United States China China | WILLIS, DOUGLAS M |
| 2021-09-10 | 17472583 | INHIBITORS OF MENIN-MLL INTERACTION | BIOMEA FUSION, INC. | Patented Case | 2023-12-19 | 11845753 | US20220024936A1 | Thomas BUTLER Jim Palmer Ravi Upasani Matthew Welsch Sridhar Vempati Brendan Kelly Edward Painter | United States Australia United States United States United States Ireland United States | MOORE, SUSANNA |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |